Similar articles for PMID: 30151832

Year	Number of Results
1993	1
2000	1
2001	1
2003	1
2007	1
2008	5
2009	2
2011	5
2012	6
2013	7
2014	9
2015	19
2016	21
2017	20
2018	12
2019	6
2020	7
2021	4
2022	6
2023	2
2024	0

1

HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes.

Cheraghlou S, Torabi SJ, Husain ZA, Otremba MD, Osborn HA, Mehra S, Yarbrough WG, Burtness BA, Judson BL. Cheraghlou S, et al. Laryngoscope. 2019 Mar;129(3):684-691. doi: 10.1002/lary.27475. Epub 2018 Aug 27. Laryngoscope. 2019. PMID: 30151832

2

Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection.

Axelsson L, Nyman J, Haugen-Cange H, Bove M, Johansson L, De Lara S, Kovács A, Hammerlid E. Axelsson L, et al. J Otolaryngol Head Neck Surg. 2017 Jun 10;46(1):45. doi: 10.1186/s40463-017-0223-1. J Otolaryngol Head Neck Surg. 2017. PMID: 28601094 Free PMC article.

3

Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.

Demiroz C, Vainshtein JM, Koukourakis GV, Gutfeld O, Prince ME, Bradford CR, Wolf GT, McLean S, Worden FP, Chepeha DB, Schipper MJ, McHugh JB. Demiroz C, et al. Head Neck. 2014 Nov;36(11):1589-1595. doi: 10.1002/hed.23479. Epub 2013 Nov 18. Head Neck. 2014. PMID: 23996575 Free PMC article.

4

Validation of Human Papillomavirus as a Favourable Prognostic Marker and Analysis of CD8⁺ Tumour-infiltrating Lymphocytes and Other Biomarkers in Cancer of Unknown Primary in the Head and Neck Region.

Sivars L, Landin D, Grün N, Vlastos A, Marklund L, Nordemar S, Ramqvist T, Munck-Wikland E, Näsman A, Dalianis T. Sivars L, et al. Anticancer Res. 2017 Feb;37(2):665-673. doi: 10.21873/anticanres.11362. Anticancer Res. 2017. PMID: 28179315

5

Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.

Bersani C, Sivars L, Haeggblom L, DiLorenzo S, Mints M, Ährlund-Richter A, Tertipis N, Munck-Wikland E, Näsman A, Ramqvist T, Dalianis T. Bersani C, et al. Oncotarget. 2017 May 23;8(21):35339-35350. doi: 10.18632/oncotarget.15240. Oncotarget. 2017. PMID: 28525363 Free PMC article.

6

Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base.

Cheraghlou S, Yu PK, Otremba MD, Park HS, Bhatia A, Zogg CK, Mehra S, Yarbrough WG, Judson BL. Cheraghlou S, et al. Cancer. 2018 Feb 15;124(4):717-726. doi: 10.1002/cncr.31104. Epub 2017 Dec 15. Cancer. 2018. PMID: 29243245 Free article.

7

Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study.

Schroeder L, Boscolo-Rizzo P, Dal Cin E, Romeo S, Baboci L, Dyckhoff G, Hess J, Lucena-Porcel C, Byl A, Becker N, Alemany L, Castellsagué X, Quer M, León X, Wiesenfarth M, Pawlita M, Holzinger D. Schroeder L, et al. Eur J Cancer. 2017 Mar;74:73-81. doi: 10.1016/j.ejca.2016.12.020. Epub 2017 Feb 10. Eur J Cancer. 2017. PMID: 28335889 Free article.

8

Unilateral radiotherapy treatment for p16/human papillomavirus-positive squamous cell carcinoma of unknown primary in the head and neck.

Tiong A, Rischin D, Young RJ, Herschtal A, Solomon B, D'Costa I, Fua T, Liu C, Coleman A, Kleid S, Dixon BJ, Corry J. Tiong A, et al. Laryngoscope. 2018 Sep;128(9):2076-2083. doi: 10.1002/lary.27131. Epub 2018 Feb 26. Laryngoscope. 2018. PMID: 29481710

9

Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.

Spreafico A, Huang SH, Xu W, Granata R, Liu CS, Waldron JN, Chen E, Ringash J, Bayley A, Chan KK, Hope AJ, Cho J, Razak AA, Hansen A, Jang R, Perez-Ordonez B, Weinreb I, Bossi P, Orlandi E, Licitra LF, Song Y, O'Sullivan B, Siu LL, Kim J. Spreafico A, et al. Eur J Cancer. 2016 Nov;67:174-182. doi: 10.1016/j.ejca.2016.08.013. Epub 2016 Sep 24. Eur J Cancer. 2016. PMID: 27669504

10

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Fakhry C, et al. J Natl Cancer Inst. 2008 Feb 20;100(4):261-9. doi: 10.1093/jnci/djn011. Epub 2008 Feb 12. J Natl Cancer Inst. 2008. PMID: 18270337 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year